Masaki Tamura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Masaki Tamura has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Ikunosuke Tsuneki
2 shared publicationsKenichi Tanaka
Department of Obstetrics and Gynecology, Niigata University School of Medicine, Niigata, Japan
2 shared publicationsRyo Tamura
2 shared publicationsShota Nishijima
2 shared publications- Takumi Kurabayashi
Department of Obstetrics and Gynecology, Niigata City General Hospital, Niigata, Japan
2 shared publications Toru Yanase
2 shared publications
Latest Publications
- 1 April 2011
- Vol. 38 (4) , 689-92
[Orally administered polaprezinc significantly improves taste disorders in ovarian cancer patient undergoing chemotherapy].
The subject was a 75-year-old female who was receiving paclitaxel and carboplatin(TC)chemotherapy every other week after surgery for ovarian cancer. She greatly complained of taste disorders after four cycles(of every other week administration) of TC chemotherapy. To understand how the taste disorder was caused by chemotherapy objectively, taste examinations were conducted for the patient in our department. These examinations were conducted after receiving the informed consent from the patient. The authors conducted taste examinations for the patient using serum zinc measurement, tongue cell culture, electrogustometry, and filter paper disc tests(before and after starting chemotherapy), and found that her serum zinc level fell significantly after four cycles of chemotherapy. Orally disintegrating tablets of polaprezinc were then administered to the patient, after which the subjective symptom of taste disorder improved. Her serum zinc level increased, and the electrogustometric threshold rapidly fell(an improvement). The filter paper disc test showed some improvement, particularly in the glossopharyngeal nerve and the greater petrosal nerve field.
- 1 April 2011
- Vol. 38 (4) , 689-92
[Orally administered polaprezinc significantly improves taste disorders in ovarian cancer patient undergoing chemotherapy].
The subject was a 75-year-old female who was receiving paclitaxel and carboplatin(TC)chemotherapy every other week after surgery for ovarian cancer. She greatly complained of taste disorders after four cycles(of every other week administration) of TC chemotherapy. To understand how the taste disorder was caused by chemotherapy objectively, taste examinations were conducted for the patient in our department. These examinations were conducted after receiving the informed consent from the patient. The authors conducted taste examinations for the patient using serum zinc measurement, tongue cell culture, electrogustometry, and filter paper disc tests(before and after starting chemotherapy), and found that her serum zinc level fell significantly after four cycles of chemotherapy. Orally disintegrating tablets of polaprezinc were then administered to the patient, after which the subjective symptom of taste disorder improved. Her serum zinc level increased, and the electrogustometric threshold rapidly fell(an improvement). The filter paper disc test showed some improvement, particularly in the glossopharyngeal nerve and the greater petrosal nerve field.
- 1 May 2010
- Vol. 20 (5) , 672-81
[Secondary osteoporosis UPDATE. Bone metabolic change and osteoporosis during pregnancy and lactation].
Calcium transfer from the mother to the infant during pregnancy and lactation plays an extremely important role in the bone health of the mother and neonate. Calcium aids in bone health through all ages but is especially crucial during pregnancy and lactation. Changes in the structure and metabolism of bone during pregnancy and the early stage of postpartum are evaluated by investigating bone mineral density (BMD), bone histomorphometry and bone markers of human or animal models. The bone resorption increased at the end of pregnancy and lactation, and the bone formation increases and the bone structure is almost recovered after cessation of lactating in postpartum. Puerperal BMD remained static over the subsequent 5-10 years. If the women have a low BMD at this stage of their reproductive life, it tends not to improve over this time. Perhaps identification of this at-risk group may lead to effective interventions to reduce fracture risk in later life.
- 1 May 2010
- Vol. 20 (5) , 672-81
[Secondary osteoporosis UPDATE. Bone metabolic change and osteoporosis during pregnancy and lactation].
Calcium transfer from the mother to the infant during pregnancy and lactation plays an extremely important role in the bone health of the mother and neonate. Calcium aids in bone health through all ages but is especially crucial during pregnancy and lactation. Changes in the structure and metabolism of bone during pregnancy and the early stage of postpartum are evaluated by investigating bone mineral density (BMD), bone histomorphometry and bone markers of human or animal models. The bone resorption increased at the end of pregnancy and lactation, and the bone formation increases and the bone structure is almost recovered after cessation of lactating in postpartum. Puerperal BMD remained static over the subsequent 5-10 years. If the women have a low BMD at this stage of their reproductive life, it tends not to improve over this time. Perhaps identification of this at-risk group may lead to effective interventions to reduce fracture risk in later life.
- 25 July 2006
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 56 (4) , 237-242
Prophylactic Therapy for Patients with Reproductive Failure Who were Positive for Anti‐Phospholipid Antibodies
Problem To elucidate the efficacy of the treatment using a Japanese‐modified Chinese herbal medicine, Sairei‐to, and low‐dose aspirin with or without a corticosteroid hormone for the patients with adverse pregnancy histories positive for anti‐phospholipid antibodies. Methods of study Fifteen cases positive for anti‐phospholipid antibodies, who had experienced preterm delivery in which an extremely low birthweight infant (<1000 g) was born as a result of intrauterine growth restriction with or without severe preeclampsia, were treated with the medication according to the current protocol. Four cases with the same condition, who were treated with only low‐dose aspirin, or without medication, were chosen as a control population. The pregnancy outcome was compared between the two groups. Results The rate of patients in whom the next pregnancy continued until the 36th week of gestation or later was significantly higher in treated patients (80.0%) compared with the control population (0%). Conclusions In this series, we obtained case report data that Sairei‐to may provide some benefit for patients with reproductive disorders positive for anti‐phospholipid antibodies; however, randomized controlled trial evidence is needed before current treatment can be recommended.
- 25 July 2006
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 56 (4) , 237-242
Prophylactic Therapy for Patients with Reproductive Failure Who were Positive for Anti‐Phospholipid Antibodies
Problem To elucidate the efficacy of the treatment using a Japanese‐modified Chinese herbal medicine, Sairei‐to, and low‐dose aspirin with or without a corticosteroid hormone for the patients with adverse pregnancy histories positive for anti‐phospholipid antibodies. Methods of study Fifteen cases positive for anti‐phospholipid antibodies, who had experienced preterm delivery in which an extremely low birthweight infant (<1000 g) was born as a result of intrauterine growth restriction with or without severe preeclampsia, were treated with the medication according to the current protocol. Four cases with the same condition, who were treated with only low‐dose aspirin, or without medication, were chosen as a control population. The pregnancy outcome was compared between the two groups. Results The rate of patients in whom the next pregnancy continued until the 36th week of gestation or later was significantly higher in treated patients (80.0%) compared with the control population (0%). Conclusions In this series, we obtained case report data that Sairei‐to may provide some benefit for patients with reproductive disorders positive for anti‐phospholipid antibodies; however, randomized controlled trial evidence is needed before current treatment can be recommended.
- 1 November 1997
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 14 (10) , 641-643
A Case of Mosaic Tetrasomy 12P (Pallister-Killian Syndrome) Diagnosed Prenatally: Comparison Of Chromosome Analyses Of Various Cells Obtained From The Patient
A pregnant woman was referred to our hospital at the 29th week of gestation with the symptom of polyhydramnios; diaphragmatic herniation of the fetus was suspected. Fetal chromosome anlaysis was performed using fibroblasts obtained by aminocentesis, and mosaicism of 46,XX and isochromosome of 12p were diagnosed. Out of 50 karyotyped cells, 19 (38.0%) showed the tetrasomy of the isochromosome of 12p. The mother vaginally delivered a baby girl who died just after delivery. The analysis of cord blood lymphocytes revealed only 0.5% incidence of tetrasomy of 12p. The incidence of tetrasomy was 8.0% for the placental chorionic villi, 48.0% for the fibroblasts obtained from the umbilical cord, and 70.0% for the skin fibroblasts. Thus, the diagnosis of Pallister-Kilian Syndrome (PKS) is confirmed by mosaicism of i(12p), that is, the affected patients exhibit tissue-specific mosaicism, with the abnormal karyotype expression in limited lymphocytes, but marked in fibroblasts.
- 1 November 1997
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 14 (10) , 641-643
A Case of Mosaic Tetrasomy 12P (Pallister-Killian Syndrome) Diagnosed Prenatally: Comparison Of Chromosome Analyses Of Various Cells Obtained From The Patient
A pregnant woman was referred to our hospital at the 29th week of gestation with the symptom of polyhydramnios; diaphragmatic herniation of the fetus was suspected. Fetal chromosome anlaysis was performed using fibroblasts obtained by aminocentesis, and mosaicism of 46,XX and isochromosome of 12p were diagnosed. Out of 50 karyotyped cells, 19 (38.0%) showed the tetrasomy of the isochromosome of 12p. The mother vaginally delivered a baby girl who died just after delivery. The analysis of cord blood lymphocytes revealed only 0.5% incidence of tetrasomy of 12p. The incidence of tetrasomy was 8.0% for the placental chorionic villi, 48.0% for the fibroblasts obtained from the umbilical cord, and 70.0% for the skin fibroblasts. Thus, the diagnosis of Pallister-Kilian Syndrome (PKS) is confirmed by mosaicism of i(12p), that is, the affected patients exhibit tissue-specific mosaicism, with the abnormal karyotype expression in limited lymphocytes, but marked in fibroblasts.